Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study

被引：686

作者：

Barron, Emma ^{[1
]}

Bakhai, Chirag ^{[2
]}

Kar, Partha ^{[2
,3
]}

Weaver, Andy ^{[2
]}

Bradley, Dominique ^{[2
]}

Ismail, Hassan ^{[2
]}

Knighton, Peter ^{[4
]}

Holman, Naomi ^{[2
,4
,5
]}

Khunti, Kamlesh ^{[6
]}

Sattar, Naveed ^{[5
]}

Wareham, Nicholas J. ^{[7
]}

Young, Bob ^{[8
]}

Valabhji, Jonathan ^{[2
,9
,10
]}

机构：

[1] Publ Hlth England, York, N Yorkshire, England

[2] NHS England & NHS Improvement, London SE1 61H, England

[3] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England

[4] NHS Digital, Leeds, W Yorkshire, England

[5] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland

[6] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England

[7] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England

[8] Diabet UK, London, England

[9] Imperial Coll Healthcare NHS Trust, Dept Diabet & Endocrinol, St Marys Hosp, London, England

[10] Imperial Coll London, Div Diabet Endocrinol & Metab, London, England

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 10期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/S2213-8587(20)30272-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background Although diabetes has been associated with COVID-19-related mortality, the absolute and relative risks for type 1 and type 2 diabetes are unknown. We assessed the independent effects of diabetes status, by type, on in hospital death in England in patients with COVID-19 during the period from March 1 to May 11, 2020. Methods We did a whole-population study assessing risks of in-hospital death with COVID-19 between March 1 and May 11, 2020. We included all individuals registered with a general practice in England who were alive on Feb 16, 2020. We used multivariable logistic regression to examine the effect of diabetes status, by type, on in-hospital death with COVID-19, adjusting for demographic factors and cardiovascular comorbidities. Because of the absence of data on total numbers of people infected with COVID-19 during the observation period, we calculated mortality rates for the population as a whole, rather than the population who were infected. Findings Of the 61 414 470 individuals who were alive and registered with a general practice on Feb 16, 2020, 263 830 (0.4%) had a recorded diagnosis of type 1 diabetes, 2 864 670 (4.7%) had a diagnosis of type 2 diabetes, 41 750 (0.1%) had other types of diabetes, and 58 244 220 (94.8%) had no diabetes. 23 698 in-hospital COVID-19related deaths occurred during the study period. A third occurred in people with diabetes: 7434 (31.4%) in people with type 2 diabetes, 364 (1.5%) in those with type 1 diabetes, and 69 (0.3%) in people with other types of diabetes. Unadjusted mortality rates per 100 000 people over the 72-day period were 27 (95% CI 27-28) for those without diabetes, 138 (124-153) for those with type 1 diabetes, and 260 (254-265) for those with type 2 diabetes. Adjusted for age, sex, deprivation, ethnicity, and geographical region, compared with people without diabetes, the odds ratios (ORs) for in-hospital COVID-19-related death were 3.51 (95% CI 3.16-3.90) in people with type 1 diabetes and 2.03 (1.97-2.09) in people with type 2 diabetes. These effects were attenuated to ORs of 2.86 (2.58-3.18) for type 1 diabetes and 1.80 (1.75-1.86) for type 2 diabetes when also adjusted for previous hospital admissions with coronary heart disease, cerebrovascular disease, or heart failure. Interpretation The results of this nationwide analysis in England show that type 1 and type 2 diabetes were both independently associated with a significant increased odds of in-hospital death with COVID-19. Copyright (c) 2020 Elsevier Ltd. All rights reserved.

引用

页码：813 / 822

页数：10

共 16 条

[1] Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States [J].